Altshuler Shaham LTD Keros Therapeutics, Inc. Transaction History

Altshuler Shaham LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$26.03 - $67.04 $20,537 - $52,894	-789 Reduced 2.26%	34,074 $941,000
Q1 2022 May 16, 2022	SELL	$42.12 - $59.36 $442,260 - $623,280	-10,500 Reduced 23.15%	34,863 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $668,731 - $998,642	22,847 Added 101.47%	45,363 $1.8 Million
Q4 2020 Feb 16, 2021	SELL	$36.0 - $82.74 $109,080 - $250,702	-3,030 Reduced 11.86%	22,516 $1.59 Million
Q3 2020 Nov 10, 2020	BUY	$27.04 - $62.21 $690,763 - $1.59 Million	25,546 New	25,546 $985,000

174

30.3M

76.8K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.77B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.